Back to search results

Viome's Precision Nutrition Program for Diabetes

This study is testing if Viome's Precision Nutrition Program (VPNP) can help lower HbA1c levels in people with diabetes. HbA1c is a measure of your average blood sugar over the past 2-3 months. You might be able to join if you are 18 or older, can read English, and have an HbA1c between 6.5% and 8.9%. The study will look at your HbA1c and fasting insulin levels after 4 months to see if the program works. The current status of this study is unclear, and it plans to enroll 100 participants.

Study design
This is a randomized, placebo-controlled study, meaning participants will be randomly assigned to receive either the active program or a placebo. It plans to enroll 100 participants.
What's involved
You would complete online questionnaires, have blood draws, and collect at-home samples (blood, stool, saliva) at the beginning and end of the 90-day study. You would also follow dietary recommendations and take supplements for 90 days.
Compensation
Not stated in the trial record.
Follow-up
The primary endpoints, HbA1c and fasting insulin levels, are measured at 4 months after starting the program.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06185192

Efficacy of Viome's Precision Nutrition Program Towards Reducing HbA1c

Recruiting
NAAges 18+InterventionalTreatment
Viome
~100 participants
Updated 2025-01-29 on ClinicalTrials.gov
What's tested:Viome's Precision Nutrition Program (VPNP)

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
HbA1c levels
Measured over 4 months
+1 more outcome measured

Conditions

Diabetes

Explore related trials

Diabetes Mellitus

Where it's being run

1 sites across 1 states
Washington1

Study leadership

  • Momchilo Vuyisich · PRINCIPAL_INVESTIGATOR · Viome

Who to contact

Mory Mehrtash
[email protected]
(425) 300-6933
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Signed and dated informed consent form and medical release prior to any trial-specific procedures are performed
Females and males aged 18 years or older
Able to speak and read English
HbA1c between 6.5-8.9% (inclusive), tested within the past 30 days
Willing and able to visit a Quest Diagnostic Patient Service Center (PSC)
Willing and able to follow the trial instructions and Viome's Precision Nutrition Program
Willing and able to use a smartphone and Viome app.

Exclusion

Antibiotic use within one month of the GI test
Gestation within previous 6 month
Current (or previous) use of medications that increase insulin (sulfonylureas, such as glimepiride, glipizide, glyburide, etc.)
Current (or previous) use of exogenous insulin (such as Tresiba, Lantus, Toujeo, Levemir, Humalog, Novolog, Apidra, Fiasp, etc.)
On a specific diet, such as ketogenic, for the purpose of reducing HbA1c and/or weight within the previous month
Taking diet pills
Allergy to an ingredient in the MH capsule or stick pack
Currently on an investigational product
Significant surgery or medical procedure planned
Diet or lifestyle change during the trial period, besides those appropriate for trial arm Has followed Viome nutritional recommendations (foods and/or supplements)

What this trial measures

  • HbA1c levels4 months

    HbA1c changes in individuals in the interventional arm compared to baseline measurement.

  • Fasting Insulin levels4 months

    Change in fasting insulin levels in those in the interventional arm compared to baseline measurement.